Numerous studies have shown that amyloid-β (Aβ) modulate intracellular metabolic cascades and an intracellular Ca2+ homeostasis and a cell surface NMDA receptor expression alteration in Alzheimer's disease (AD). However most of these findings have been obtained by using non-physiological Aβ concentrations. The present study deals with the effect of low Aβ concentrations on cellular homeostasis. We used nerve growth factor-differentiated PC12 cells and murine cortical neurons sequentially treated with low chronic monomeric or small oligomeric Aβ concentrations and high acute oligomeric Aβ concentrations to bring out a priming effect of chronic treatment on subsequently high Aβ concentrations-elicited cellular response. Both cell types indeed...
Alzheimer\u27s disease (AD) is characterized by slow, progressive neurodegeneration leading to sever...
Several different receptor proteins have been identified that bind monomeric, oligomeric, or fibrill...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
SummarySoluble oligomers of amyloid β (Aβ) play a role in the memory impairment characteristic of Al...
AbstractSoluble oligomers of the amyloid-β peptide have been implicated as proximal neurotoxins in A...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Intracellular accumulation of amyloid-β (Aβ) protein has been proposed as an early event in AD patho...
Amyloid beta (Aβ) is an extracellular 39–43 residue long peptide present in the mammalian cerebrospi...
AbstractAlzheimer's disease (AD) is characterized by the aggregation and subsequent deposition of mi...
Amyloid β-protein (Aβ) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, hig...
Amyloid fibrils found in plaques in Alzheimer’s disease (AD) brains are composed of amyloid-β peptid...
AbstractFibril deposit formation of amyloid β-protein (Aβ) in the brain is a hallmark of Alzheimer's...
Oligomers of the amyloid β peptide (Aβo) are becoming the most likely neurotoxin in Alzheimer’s dise...
Oligomeric amyloid-β 1-42 (Aβ-42) peptides are considered to be the most toxic species connected to ...
Alzheimer's disease (AD) is the most common cause of age-related dementia. The neuropathological hal...
Alzheimer\u27s disease (AD) is characterized by slow, progressive neurodegeneration leading to sever...
Several different receptor proteins have been identified that bind monomeric, oligomeric, or fibrill...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
SummarySoluble oligomers of amyloid β (Aβ) play a role in the memory impairment characteristic of Al...
AbstractSoluble oligomers of the amyloid-β peptide have been implicated as proximal neurotoxins in A...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Intracellular accumulation of amyloid-β (Aβ) protein has been proposed as an early event in AD patho...
Amyloid beta (Aβ) is an extracellular 39–43 residue long peptide present in the mammalian cerebrospi...
AbstractAlzheimer's disease (AD) is characterized by the aggregation and subsequent deposition of mi...
Amyloid β-protein (Aβ) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, hig...
Amyloid fibrils found in plaques in Alzheimer’s disease (AD) brains are composed of amyloid-β peptid...
AbstractFibril deposit formation of amyloid β-protein (Aβ) in the brain is a hallmark of Alzheimer's...
Oligomers of the amyloid β peptide (Aβo) are becoming the most likely neurotoxin in Alzheimer’s dise...
Oligomeric amyloid-β 1-42 (Aβ-42) peptides are considered to be the most toxic species connected to ...
Alzheimer's disease (AD) is the most common cause of age-related dementia. The neuropathological hal...
Alzheimer\u27s disease (AD) is characterized by slow, progressive neurodegeneration leading to sever...
Several different receptor proteins have been identified that bind monomeric, oligomeric, or fibrill...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...